Yahoo Finance

SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma

STOCKHOLM, Feb. 19, 2026 /PRNewswire/ --SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that Nevisense (EIS) is ...

Study that highlights Nevisense potential for prediction of AD published in leading journal

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced the publication of a ...
TMCnet

SciBase announces that the board of directors has resolved on the record date for the reverse share split

SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that the board of directors has resolved on the record date for ...
Yahoo Finance

SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes

STOCKHOLM, May 18, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced the presentation of a new ...
Capitalbolsa

SciBase publishes the Annual report for 2025

STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com. A pdf-version of the annual report is enclosed ...
PR Newswire

Increased commitment in SciBase rights issue

STOCKHOLM, Jan. 22, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announces it has been informed that Life ...

SciBase: Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study

SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication ...
Nasdaq

Castle Biosciences Enters Collaboration with SciBase to Develop Diagnostic Test for Atopic Dermatitis Flares

Castle Biosciences, Inc. has announced a collaboration with SciBase Holding AB to utilize SciBase's Electrical Impedance Spectroscopy technology to develop a diagnostic test aimed at predicting flares ...